Bioadaptives, Inc. (BDPT) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1015 S CIMARRON RD
LAS VEGAS, NV 89145
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments83513568119
Cash and cash equivalents8351203819
Short-term investments001530100
Inventory, net of allowances, customer advances and progress billings51411  
Inventory51411   
Prepaid expense1     
Deposits current assets   222
Total current assets:891924770120
Noncurrent Assets
Property, plant and equipment   11 
Intangible assets, net (including goodwill)60    
Intangible assets, net (excluding goodwill)60     
Total noncurrent assets:60  11 
TOTAL ASSETS:1491924771120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2488830343 
Accounts payable   343 
Accrued liabilities63 0   
Interest and dividends payable    1 
Other undisclosed accounts payable and accrued liabilities1858830   
Debt4034057   
Derivative instruments and hedges, liabilities557827    
Due to related parties3478501512632
Other undisclosed current liabilities  7772541 
Total current liabilities:1,2421,3988642117132
Noncurrent Liabilities
Total liabilities:1,2421,3988642117132
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,093)(1,379)(840)(203)(0)88
Common stock522111
Additional paid in capital5,5584,2253,9172,6732,624206
Accumulated other comprehensive loss   (57)(31)(100)
Accumulated deficit(6,656)(5,606)(4,759)(2,821)(2,594) 
Other undisclosed stockholders' equity attributable to parent0    (18)
Total stockholders' equity:(1,093)(1,379)(840)(203)(0)88
TOTAL LIABILITIES AND EQUITY:1491924771120

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
Revenues201610 0 
Other income    0
Cost of revenue(10)(10)(5)   
Gross profit:1065 0 
Operating expenses(646)(260)(239)(227)(2,436) 
Other operating expense, net
(Other Expenses)
(414)(593)    
Other undisclosed operating loss    (0) 
Operating loss:(1,050)(847)(234)(227)(2,436) 
Nonoperating income (expense)1,376 (5)(0)(139) 
Investment income, nonoperating90 (198)   
Gain on sale of leased assets, net, operating leases1,286     
Interest and debt expense(323)133199(0)(1) 
Income (loss) from continuing operations before equity method investments, income taxes:3(715)(40)(228)(2,576) 
Other undisclosed loss from continuing operations before income taxes (133)(199)   
Net income (loss):3(847)(239)(228)(2,576) 
Other undisclosed net income (loss) attributable to parent(1,053)  01 
Net loss attributable to parent:(1,050)(847)(239)(227)(2,575) 
Preferred stock dividends and other adjustments194     
Net loss available to common stockholders, diluted:(856)(847)(239)(227)(2,575) 

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
12/31/2013
Net income (loss):3(847)(239)(228)(2,576) 
Comprehensive income (loss):3(847)(239)(228)(2,576) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (25)69 
Comprehensive income (loss), net of tax, attributable to parent:3(847)(239)(253)(2,507) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: